A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland. Developed by international pharmaceutical company Pfizer Inc.

Both asthma and chronic obstructive pulmonary disease (COPD) are airway disorders associated with elevated, uncontrolled inflammation in respiratory tissues. Spikes in inflammation culminate in ...

A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, ...

In the U.S., 25 million people suffer from asthma, the majority of which have allergic asthma. Allergic asthma can be life threatening. This makes access to prompt, accurate diagnosis and appropriate ...

AstraZeneca today announced that it has entered an agreement with Abbott, a global healthcare company, to develop companion diagnostic tests to identify patients with severe asthma who are most likely ...

Worldwide, asthma is the most common chronic respiratory illness that affects children, particularly Puerto Rican and Black youths, who experience higher rates of asthma and asthma-related deaths ...

Asthma–COPD overlap (ACO) is a term that encompasses patients with characteristics of 2 conditions, asthma and chronic obstructive pulmonary disease (COPD). A recent study from Spain sought to ...

Sanofi plans to take asthma research where it has not gone before. A new partnership with Mount Sinai Health System and advanced analytics firm Sema4 will create a digital asthma laboratory where ...

Medically reviewed by Sanja Jelic, MD Key Takeaways Asthma can be caused by genetics, like having a parent with asthma.

Lab tests play a key role in clinical decision-making. More than 4000 lab tests are available, and an estimated 70% of clinical decisions are based on their results. Correct interpretation is critical ...